SCHEMBL3671320

SCHEMBL3671320

COc1cccc(C(CNC2=NCCO2)c2cncc(F)c2)c1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.40
CTSA P10619 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
PKM P14618 1/20 0.33
ADRA2A P08913 1/20 0.32
ADRA1A P35348 1/20 0.32
ALDH1A1 P00352 4/20 0.32
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32
USP2 O75604 1/20 0.32
MAPT P10636 1/20 0.32
KCNH2 Q12809 2/20 0.32
P4HB P07237 1/20 0.32
SMAD3 P84022 1/20 0.32
DRD2 P14416 1/20 0.32
ADRA2B P18089 1/20 0.32
DRD1 P21728 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3804488 0.89 TAAR1 (0.40) TAAR1CTSAMEN1KMT2AADRA2A
SCHEMBL3672714 0.83 IDH1 (0.32)
SCHEMBL3671318 0.79 TAAR1 (0.39) TAAR1MEN1KMT2APKMADRA2A
SCHEMBL3665641 0.76 ADRA2A (0.33) TAAR1CTSAADRA2AADRA1A
SCHEMBL3414425 0.74 TAAR1 (0.44) TAAR1ADRA2AADRA1AKCNH2ADRA2B
SCHEMBL3670065 0.73 TAAR1 (0.38) TAAR1ADRA2AADRA1ATSHRKCNH2
SCHEMBL3673459 0.71 P2RX7 (0.41)
SCHEMBL3673071 0.71 ADRA2A (0.47) TAAR1ADRA2AADRA1A
SCHEMBL12637698 0.70 TAAR1 (0.42) TAAR1MEN1KMT2AADRA2AADRA1A
SCHEMBL12637708 0.69 TAAR1 (0.39) TAAR1ADRA2AADRA1AALDH1A1P4HB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2242753-A1 OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2010-10-27 EP disclosed
EP-2240468-A1 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2010-10-20 EP disclosed
WO-2009091759-A1 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2009-07-23 WO disclosed
WO-2009091760-A1 OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2009-07-23 WO disclosed